AAAAAA
Results: 101-125/203
Authors:
KADIJA K
SCHMITZ N
SEYBOTH P
Citation: K. Kadija et al., ANTIPROTON PRODUCTION IN NUCLEON-NUCLEUS AND NUCLEUS-NUCLEUS COLLISIONS AT THE CERN-SPS, Zeitschrift fur Physik. C, Particles and fields, 71(2), 1996, pp. 239-241
Authors:
BURKOT W
COGHEN T
CZYZEWSKI J
WITTEK W
ADERHOLZ M
GUY J
JONES GT
KATZ UF
MARAGE P
MORRISON DRO
MYATT G
SCHMITZ N
VENUS W
Citation: W. Burkot et al., NUCLEAR ATTENUATION OF FAST HADRONS PRODUCED IN CHARGED-CURRENT NU-INTERACTION AND (NU)OVER-BAR-INTERACTION IN NEON, Zeitschrift fur Physik. C, Particles and fields, 70(1), 1996, pp. 47-53
Authors:
SCHMITZ N
LINCH DC
DREGER P
GOLDSTONE AH
BOOGAERTS MA
FERRANT A
DEMUYNCK HMS
LINK H
ZANDER A
BARGE A
BORKETT K
Citation: N. Schmitz et al., RANDOMIZED TRIAL OF FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LYMPHOMA PATIENTS, Lancet, 347(8998), 1996, pp. 353-357
Authors:
GASSMANN W
SCHMITZ N
LOFFLER H
DEWITTE T
Citation: W. Gassmann et al., INTENSIVE CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES, Seminars in hematology, 33(3), 1996, pp. 196-205
Authors:
SCHMITZ N
BACIGALUPO A
LABOPIN M
MAJOLINO I
LAPORTE JP
BRINCH L
COOK G
DELILIERS GL
LANGE A
ROZMAN C
GARCIACONDE J
FINKE J
DOMINGOALBOS A
GRATWOHL A
Citation: N. Schmitz et al., TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FROM HLA-IDENTICAL SIBLING DONORS, British Journal of Haematology, 95(4), 1996, pp. 715-723
Authors:
GRATWOHL A
HERMANS J
VONBIEZEN A
ARCESE W
DEBUSSCHER L
ERNST P
FERRANT A
FRASSONI F
GAHRTON G
IRIONDO A
KOLB HJ
LINK H
NIEDERWIESER D
RUUTU T
SCHATTENBERG A
SCHMITZ N
SIEGERT W
TORRESGOMEZ A
VERNANT JP
ZWAAN FE
APPERLEY J
Citation: A. Gratwohl et al., SPLENIC IRRADIATION BEFORE BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA, British Journal of Haematology, 95(3), 1996, pp. 494-500
Authors:
RUSSELL N
GRATWOHL A
SCHMITZ N
Citation: N. Russell et al., THE PLACE OF BLOOD STEM-CELLS IN ALLOGENEIC TRANSPLANTATION, British Journal of Haematology, 93(4), 1996, pp. 747-753
Authors:
EULER HH
MARMONT AM
BACIGALUPO A
FASTENRATH S
DREGER P
HOFFKNECHT M
ZANDER AR
SCHALKE B
HAHN U
HAAS R
SCHMITZ N
Citation: Hh. Euler et al., EARLY RECURRENCE OR PERSISTENCE OF AUTOIMMUNE-DISEASES AFTER UNMANIPULATED AUTOLOGOUS STEM-CELL TRANSPLANTATION, Blood, 88(9), 1996, pp. 3621-3625
Authors:
DREGER P
KUSE R
VONNEUHOFF N
VIEHMANN K
SONNEN R
HAFERLACH T
SUTTORP M
LOFFLER H
SCHMITZ N
Citation: P. Dreger et al., EARLY STEM-CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 487-487
Authors:
ZEIS M
UHAREK L
GLASS B
STEINMANN J
DREGER P
SCHMITZ N
Citation: M. Zeis et al., SUPERIOR GRAFT-VS-LEUKEMIA EFFECTS AFTER TRANSPLANTATION OF MURINE ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AS COMPARED TO BONE-MARROW, Blood, 88(10), 1996, pp. 970-970
Authors:
SUTTORP M
FUHRER M
BENDERGOTZE C
DREGER P
VONNEUHOFF N
SCHMITZ N
Citation: M. Suttorp et al., RESIDUAL RECIPIENT CELLS ARE DETECTABLE FOR A LONG-PERIOD FOLLOWING BMT WITH UNMANIPULATED GRAFTS, Blood, 88(10), 1996, pp. 2390-2390
Authors:
ARNOLD R
BUNJES D
EINSELE H
FAUSER A
FINKE J
GRAMATZKI M
HAAS R
HEYLL A
KOLB HJ
KOLBE K
LINK H
MARTIN H
SCHAEFER UW
SCHUMACHER G
SCHMITZ N
SIEGERT W
WANDT H
ZANDER AR
MESSERER D
HOELZER D
Citation: R. Arnold et al., RESULTS OF BMT IN HIGH-RISK ADULT ALL PATIENTS TREATED IN THE GERMAN MULTICENTER ALL STUDIES, Blood, 88(10), 1996, pp. 2446-2446
Authors:
FASTENRATH S
SCHMITZ N
HAAS R
ZANDER AR
MARMONT AM
EULER HH
Citation: S. Fastenrath et al., RECURRENCE OF AUTOIMMUNE-DISEASES FOLLOWING AUTOLOGOUS AND UNMANIPULATED STEM-CELL TRANSPLANTATION, Arthritis and rheumatism, 39(9), 1996, pp. 1673-1673
Authors:
ENCK P
VONGIESEN HJ
SCHAFER A
HEYER T
GANTKE B
FLESCH S
ARENDT G
SCHMITZ N
FRIELING T
Citation: P. Enck et al., COMPARISON OF ANAL SONOGRAPHY WITH CONVENTIONAL NEEDLE ELECTROMYOGRAPHY IN THE EVALUATION OF ANAL-SPHINCTER DEFECTS, The American journal of gastroenterology, 91(12), 1996, pp. 2539-2543
IS THERE A RATIONALE FOR HIGH-DOSE CHEMOTHERAPY AS FIRST-LINE TREATMENT OF ADVANCED HODGKINS-DISEASE
Authors:
HASENCLEVER D
SCHMITZ N
DIEHL V
Citation: D. Hasenclever et al., IS THERE A RATIONALE FOR HIGH-DOSE CHEMOTHERAPY AS FIRST-LINE TREATMENT OF ADVANCED HODGKINS-DISEASE, Leukemia & lymphoma, 15, 1995, pp. 47-49
Authors:
LOFFLER H
SCHMITZ N
Citation: H. Loffler et N. Schmitz, TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA, Onkologie, 18(2), 1995, pp. 156-157
Authors:
SCHMITZ N
Citation: N. Schmitz, STRATEGIES IN TREATING RELAPSED HODGKINS- DISEASE, Onkologie, 18(1), 1995, pp. 81-82
Authors:
ALBER T
APPELSHAUSER H
BACHLER J
BARTKE J
BIALKOWSKA H
BLOOMER MA
BOCK R
BRAITHWAITE WJ
BRINKMANN D
BROCKMANN R
BUNCIC P
CHAN P
CRAMER JG
CRAMER PB
DERADO I
ECKARDT V
ESCHKE J
FAVUZZI C
FERENC D
FLEISCHMANN B
FOKA P
FUCHS M
GAZDZICKI M
GLADYSZ E
GUNTHER J
HARRIS JW
HOFFMANN M
JACOBS P
KABANA S
KADIJA K
KOSIEC J
KOWALSKI M
KUHMICHEL A
LEE JY
LJUBICIC A
MARGETIS S
MITCHELL JT
MORSE R
NAPPI E
ODYNIEC G
PAIC G
PANAGIOTOU AD
PETRIDIS A
PIPER A
POSA F
POSKANZER AM
PUHLHOFER F
RAUCH W
RENFORDT R
RETYK W
ROHRICH D
ROLAND G
ROTHARD H
RUNGE K
SANDOVAL A
SCHMITZ N
SCHMOETTEN E
SENDELBACH R
SEYBOTH P
SEYERLEIN J
SKRZYPCZAK E
SPINELLI P
STEFANSKI P
STOCK R
STROBELE H
TRAINOR TA
VASILEIADIS G
VASSILIOU M
VRANIC D
WENIG S
WOSIEK B
ZHU X
Citation: T. Alber et al., RECENT RESULTS FROM NA35, Nuclear physics. A, 590(1-2), 1995, pp. 197-213
Authors:
MARGETIS S
ALBER T
APPELSHAUSER H
BACHLER J
BARTKE J
BIALKOWSKA H
BIESER F
BLOOMER MA
BLYTH CO
BOCK R
BORMANN C
BRADY FP
BROCKMANN R
BUNCIC P
CAINES HL
CEBRA D
CHAN P
COOPER G
CRAMER JG
CRAMER PB
CSATO P
DERADO I
DUNN J
ECKARDT V
ECKHARDT F
EULER S
FERGUSON MI
FISCHER HG
FODOR Z
FOKA P
FREUND P
FUCHS M
GAL J
GAZDZICKI M
GLADYSZ E
GREBIESZKOW J
GUNTHER J
HARRIS JW
HECK W
HEGYI S
HILL LA
HUANG I
HOWE MA
IGO G
IRMSCHER D
JACOBS P
JONES PG
KADIJA K
KECSKEMETI J
KOSIEC J
KOWALSKI M
KUHMICHEL A
LASIUK B
MITCHELL JW
MOCK A
NELSON JM
ODYNIEC G
PALINKAS J
PALLA G
PANAGIOTOU AD
PETRIDIS A
PIPER A
POSKANZER AM
PRINDLE DJ
PUHLHOFER F
RAUCH W
RENFORDT R
RETYK W
RITTER HG
ROHRICH D
RUDOLPH H
RUNGE K
SANDOVAL A
SANN H
SCHAFER E
SCHMITZ N
SCHONFELDER S
SEYBOTH P
SEYERLEIN J
SIKLER F
SKRZYPCZAK E
STEFANSKI P
STOCK R
STROBELE H
SZENTPETERY I
SZIKLAI J
TOY M
TRAINOR TA
TRENTALANGE S
VASSILIOU M
VESZTERGOMBI G
VRANIC D
WENIG S
WHITTEN C
WIENOLD T
WOOD L
ZIMANYI J
ZHU XZ
ZYBERT R
Citation: S. Margetis et al., FIRST RESULTS FROM NA49 ON PB+PB COLLISIONS AT 158 GEV NUCLEON/, Nuclear physics. A, 590(1-2), 1995, pp. 355-365
Authors:
SCHMITZ N
Citation: N. Schmitz, ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION, Experimental hematology, 23(8), 1995, pp. 742-742
Authors:
ZEIS M
GLASS B
UHAREK L
STEINMANN J
SCHMITZ N
GASSMANN W
Citation: M. Zeis et al., ACTIVATION OF ALLOGENIC NK-CELLS BY IL-2 AND IL-12 RESULTS IN HIGH LYTIC ACTIVITY AGAINST FRESH HUMAN LEUKEMIA BLASTS, Experimental hematology, 23(8), 1995, pp. 787-787
Authors:
UHAREK L
GLASS B
ZEIS M
STEINMANN J
SCHMITZ N
GASSMANN W
Citation: L. Uharek et al., IMMUNOTHERAPY USING ALLOGENEIC NK CELLS AFTER BONE-MARROW TRANSPLANTATION IN MICE, Experimental hematology, 23(8), 1995, pp. 808-808
Authors:
DREGER P
VIEHMANN K
STEINMANN J
ECKSTEIN V
MULLERRUCHHOLTZ W
LOFFLER H
SCHMITZ N
Citation: P. Dreger et al., G-CSF-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION - COMPARISON OF T-CELL DEPLETION STRATEGIES USING DIFFERENT CD34(-1() SELECTION SYSTEMS OR CAMPATH), Experimental hematology, 23(2), 1995, pp. 147-154
Authors:
LINK H
SCHMITZ N
GRATWOHL A
GOLDMAN J
Citation: H. Link et al., STANDARDS FOR SPECIALIST UNITS UNDERTAKING BLOOD AND MARROW STEM-CELLTRANSPLANTS - RECOMMENDATIONS FROM THE EBMT, Bone marrow transplantation, 16(6), 1995, pp. 733-736
Authors:
RINGDEN O
LONNQVIST B
HAGGLUND H
LJUNGMAN P
SHANWELL A
LAWLOR E
SCHMITZ N
Citation: O. Ringden et al., TRANSPLANTATION WITH PERIPHERAL-BLOOD STEM-CELLS FROM UNRELATED DONORS WITHOUT SERIOUS GRAFT-VERSUS-HOST DISEASE, Bone marrow transplantation, 16(6), 1995, pp. 856-857